Skip to main content
. 2022 Mar 14;12:101. doi: 10.1038/s41398-022-01847-8

Fig. 3. Meta-analysis of randomized-controlled trials evaluating combinatorial pharmacogenomic testing.

Fig. 3

A Meta-analysis of symptom improvement. B Meta-analysis of response. C Meta-analysis of remission.